Health
New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients
MELBOURNE, Australia and ATLANTA, Aug. 5, 2019 /PRNewswire/ -- Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and continuous treatment with long-lasting effect. The Therapeutic Goods Administration has now approved the drug IL...
2019-08-05 20:00
2056
Chemist Warehouse And Smile Direct Club Team Up To Offer Customers A Straighter, More Affordable Smile
SmileShop in-store pilot offers Chemist Warehouse customers increased access to safe and convenient teeth straightening solutions SYDNEY, Aug. 5, 2019 /PRNewswire/ -- Chemist Warehouse today announced its partnership with SmileDirectClub, the US-based teledentistry pioneer, to expand access to a...
2019-08-05 06:00
2350
I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in a Phase 1 Trial of the CD73 Antibody TJD5 in the U.S. in Patients with Advanced Solid Tumors
SHANGHAI and SAN DIEGO, Aug. 1, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a China and U.S.-based clinical stage biopharmaceutical company exclusively focused on the discovery and development of potential first-in-class and best-in-class biologics in immuno-oncology and autoimmune diseases, an...
2019-08-01 20:06
2335
New Texas Imaging Center Utilizing United Imaging Equipment, Demonstrating the Innovation of Cutting-Edge Portfolio in the U.S.
HOUSTON, Aug. 1, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, today announced that Baaxten Imaging Center has opened a new facility inBrownsville, TX, which will feature United Imaging's equipment, including X-ray, MR and CT scanners...
2019-08-01 20:00
2080
111 to Announce Second Quarter 2019 Unaudited Financial Results on August 15, 2019
SHANGHAI, Aug. 1, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the second quarter endedJune 30, 2019, before U.S. markets open o...
2019-08-01 20:00
6354
Samsung BioLogics and UCB Sign Third Drug Manufacturing Deal
INCHEON, South Korea, July 31, 2019 /PRNewswire/ -- Samsung BioLogics (SBL) and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive supranuclear palsy, pending regulatory approvals. UCB's anti-tau candi...
2019-07-31 19:00
1686
GC Pharma Reports Q2 2019 Results
YONGIN, South Korea, July 30, 2019 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months endedJune 30, 2019. Key Figures Q2 2019(1) Growth(1) Total revenues KRW 35...
2019-07-30 22:31
7891
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets
REYKJAVIK, Iceland and MUMBAI, India, July 29, 2019 /PRNewswire/ -- Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today ...
2019-07-29 12:00
5594
China Biologic Products to Report Second Quarter 2019 Financial Results
BEIJING, July 26, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2019 financial resu...
2019-07-27 04:30
10364
LISCure Biosciences Has Completed Seed Funding of USD 5 Million for Bacteria-mediated Immunotherapy R&D Enhancement
SEOUL, South Korea, July 25, 2019 /PRNewswire/ -- LISCure Biosciences, a biotech company that researches and develops bacteria-mediated immunotherapy, has succeeded in attracting5 million USD of seed funding investment. NHN Investment, Shinhan Investment, and KB Securities have participated in th...
2019-07-25 21:00
2228
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
AUSTIN, Texas, July 24, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced a further strengthening of its balance sheet with an existing investor exercising the balance of its warrant to purchase$4.8 million in aggregate amount of shares of our common stock...
2019-07-25 04:05
9664
NanoCellect Biomedical Expands Distribution to Australia and New Zealand
Company enters exclusive agreement with Millennium Science Pty Ltd SAN DIEGO, California, July 24, 2019 /PRNewswire/ -- NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive agreement wit...
2019-07-24 21:57
1772
111 Signs Strategic Cooperation with Harbin Pharmaceutical Group
SHANGHAI, July 24, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced the signing of a strategic cooperation agreement with Harbin Pharmaceutical Group Holding Co., Ltd. (HPGC, SHSE: 600664), which has...
2019-07-24 20:00
8236
111 Wins Recognition as Pioneer of New Healthtech
"Growth Champion" Award for "1 Drugstore" SHANGHAI, June 23, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that its online retail pharmacy "1 Drugstore" has won two prestigious industry awards. B...
2019-07-23 21:53
7029
Shanghai Concord Medical Cancer Center has Accepted Medical Insurance Settlement from Patients from certain Yangtze River Delta Regions
BEIJING, July 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solutions provider and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced that...
2019-07-23 18:03
9721
Innopresso launches Indiegogo campaign for its touchpad-keyboard Mokibo
SEOUL, South Korea, July 23, 2019 /PRNewswire/ -- Innopresso, a member company of theBorn2Global Centre, successfully launched its smart keyboard "Mokibo" on Indiegogo (https://igg.me/at/mokibo/x#/).   Mokibo is a smart keyboard that combines the functions of a keyboard with t...
2019-07-23 15:30
2365
CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML
SUZHOU, China, July 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) announced today that it has received approval from China National Medical Products Administration (NMPA) to initiate a Phase I bridging registrational study of ivosidenib (TIBSOVO) for the treatment of rela...
2019-07-22 12:17
7266
VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China
AUSTIN, Texas, July 18, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") has executed a contract under the previously announced Memorandum of Understanding, with Shanghai Fosun Long March Medical Science Co., Ltd. ("Fosun Long March") to help introduce the Nu.Q(TM) platf...
2019-07-18 20:30
12314
Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea
SEOUL, South Korea, July 17, 2019 /PRNewswire/ -- Yuyu Pharma has received recognition as a Great Place to Work from the mayor of Jechoen city. The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equality movement that focuses on th...
2019-07-17 21:00
2618
Kazia calls for greater awareness of the deadliest brain cancer in the US
SYDNEY, July 17, 2019 /PRNewswire/ -- This Glioblastoma Awareness Day, Australian oncology-focused biotech company, Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA), calls for greater awareness of the most lethal brain cancer in the US. Glioblastoma (GBM) is the most common, complex, treatment ...
2019-07-17 20:00
7794
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38
Tan Xuguang: Unveiling New Quality Productivity in Power Solutions for Asia-Pacific Data Centers!
[Picked up by 302 media titles]
2024-06-19 21:25
Most Read
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
2024-06-19 11:00
15513
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
2024-06-20 16:24
12948
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
2024-06-19 08:05
9409